$IMRX filed an 8-K with results (Item 2.02) at 4:12 PM ET on Thu, Oct 29.
IMRX
Immuneering Corporation Class AAbout IMRX
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Moved with Pharmaceuticals peers: SDGR −9.50% · BHC −7.97% · PTCT −6.97%
From market data · Not investment advice
Moved with Pharmaceuticals peers: SDGR −9.50% · BHC −7.97% · PTCT −6.97%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check Oct 30, 7:30 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about IMRX?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›